Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02868047 · ClinicalTrials.gov registry record
Establishing Standards for Normal Pancreatic EUS
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 54
- Enrollment target
NCT02868047: Completed study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT02868047 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02868047 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
There is tremendous variability in regard to provider perception of findings on EUS for chronic pancreatitis. This study performs tandem EUS exams between expert endosonogrpahers to determine the validity of minimal standard criteria.
Interventions
- PROCEDURE Endoscopic Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2010-09 |
| Est. Completion | 2015-05 |
What the finished NCT02868047 record still lists
NCT02868047 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Endoscopic Ultrasound is the first listed.
NCT02868047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02868047 about?
NCT02868047 is a clinical study titled "Establishing Standards for Normal Pancreatic EUS". There is tremendous variability in regard to provider perception of findings on EUS for chronic pancreatitis. This study performs tandem EUS exams between expert endosonogrpahers to determine the validity of minimal standard criteria.
What is the current status of trial NCT02868047?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2010-09. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02868047?
The interventions under investigation include: Endoscopic Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT02868047?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia